|
Fosamax
Bisphosphonate :: Osteonecrosis :: ONJ :: Jaw Necrosis
Bis-Phossy Jaw ::Phossy Jaw :: Fossy Jaw
Dead Jaw :: Femur Fracture
"PLEASE NOTE: Gooch Law Firm is only accepting FOSAMAX cases for evaluation. If you feel that you may have a potential ACTONEL/ZOMETA/AREDIA case, we urge you to locate another law firm adequately suited to handle your claim."
Fosamax® (alendronate sodium), is a bisphosphonate drug medication manufactured by Merck and is used to treat osteoporosis.
FDA Review - Bisphosphonates
On August 25, 2004, the FDA released the results of its ODS Postmarketing Safety Review of various bisphosphonates, incuding Aredia (pamidronate) and Zometa (zoledronic acid), Fosamax (alendronate), Actonel (risedronate). In this report, the FDA recommended that language be added to the labels of some bisphosphonate drugs in order to advise of the risk of osteonecrosis.
Health Concerns
Some bisphosponates drugs like Fosamax may have certain side effects or problems that may cause a painful and disfiguring condition - Osteonecrosis - that causes the jaw bone to decay and die (problems with teeth) or possible femur fracture.
Merck, the manufacturer of Fosamax, may have failed to warn users of a possible side effect or problem from using the drug Fosamax- Osteonecrosis (also know as ONJ, Jaw Necrosis, Bis-Phossy Jaw, Phossy Jaw, Fossy Jaw or Dead Jaw) and/or femur fracture problems.
Bisphosphonates - e.g., Fosamax -
Medical Studies/Information
Jaw Problems
Recently, January 9, 2009, the USC School of Dentistry stated that "Even short-term use of common oral osteoporosis drugs may leave the jaw vulnerable to devastating necrosis," according to a new USC School of Dentistry study appearing in the January 1,2009 Journal of the American Dental Association (JADA).
The JADA study stated that "The findings from this study indicated that even short-term oral use of alendronate led to ONJ in a subset of patients after certain dental procedures were performed. These findings have important therapeutic and preventive implications. (Osteonecrosis; jaw; oral bisphosphonates; alendronate; extraction)"
In addition, The Alliance for Better Bone Health released a statement in connection with Actonel - bisphosphonate - and osteonecrosis of the jaw. The Alliance is made up of Proctor & Gamble (maker of actonel) and Sanofi-Aventis U.S.
In addition, The American Dental Association released a report - "Reports Address Osteonecrosis of the Jaw in Patients Receiving Bisphosphonate Therapy" - in connection with bisphosphonate drugs - e.g., fosamax, actonel, aredia and zometa - and osteonecrosis of the jaw.
In addition, The Journal of Bone and Mineral Research released a report - "Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research" - in connection with bisphosphonate drugs and osteonecrosis of the jaw.
In addition, The American Association of Oral and Maxillofacial Surgeons released a a position paper report - "American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws" - in connection with bisphosphonate drugs - e.g., fosamax, actonel, aredia and zometa - and osteonecrosis of the jaw.
In addition, The Journal of Oncology released a research/position/guideline paper report - "Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer" - in connection with bisphosphonate drugs and cancer patients (breast, multiple myeloma, Paget's disease, prostate) and osteonecrosis of the jaw.
In addition, The American Dental Association released a a clinical presentation position paper report - "Osteonecrosis of the Jaw" - in connection with the use of bisphosphonate drugs - e.g., fosamax, actonel, aredia and zometa - and osteonecrosis of the jaw.
In addition, The American Academy of Periodontology released a statement paper report - "AAP Statement on Bisphosphonates" - in connection with bisphosphonate drugs - e.g., aredia and zometa - and osteonecrosis of the jaw.
Femur Problems
In addition, a recent study has linked the drug Fosamax to a rare femur fracture. The study states that some patients on Fosamax experienced low energy fracture (fractures that may occur when someone falls from standing height). The fractures in the patients appeared in strong looking bones that didn't appear to have signs of osteoporosis. Fosamax's manufacturer, Merck didn't agree with the study.
Please navigate to the links below to find more information on personal injury and what individuals suffering from a personal injury can do to protect their legal rights or contact us.
Top of page or Home page
|